Personal information

Activities

Employment (4)

Instituto Distrital de Ciencia, Biotecnología e Innovación en Salud: Bogotá, CO

2024-02-22 to present | investigadora (Unidad de terapias avanzadas)
Employment
Source: Self-asserted source
María Teresa Herrera-Sepúlveda

Dejamu Subachoque SAS: Subachoque, CO

2023-03-23 to 2024-02-12 | Directora de Calidad (Calidad)
Employment
Source: Self-asserted source
María Teresa Herrera-Sepúlveda

Instituto Nacional de Salud: Bogotá, CO

2021-12-21 to 2022-10-22 | investigadora (Grupo de Genómica de microorganismos emergentes)
Employment
Source: Self-asserted source
María Teresa Herrera-Sepúlveda

Instituto Nacional de Salud: Bogota, CO

2016-09 to 2021-11-30 (Dirección de Investigación en Salud Pública-Grupo de parasitología)
Employment
Source: Self-asserted source
María Teresa Herrera-Sepúlveda

Education and qualifications (2)

Pontificia Universidad Javeriana: Bogota, CO

2014-01 to 2018-09 | Maestría en Ciencias Biológicas
Education
Source: Self-asserted source
María Teresa Herrera-Sepúlveda

Pontificia Universidad Javeriana: Bogota, CO

2008-07-21 to 2013-09-19 | Bióloga
Education
Source: Self-asserted source
María Teresa Herrera-Sepúlveda

Works (4)

Neutralizing responses in fully vaccinated with BNT162b2, CoronaVac, ChAdOx1, and Ad26.COV2.S against SARS-CoV-2 lineages in Colombia, 2020-2021

2022-03-15 | Preprint
Contributors: Diego A. Álvarez-Díaz; Ana Luisa Muñoz; María T. Herrera-Sepúlveda; Pilar Tavera-Rodríguez; Katherine Laiton-Donato; Carlos Franco-Muñoz; Héctor Alejandro Ruiz-Moreno; Dioselina Pelaez-Carvajal; Alejandra M. Muñoz-Suarez; Marisol Galindo et al.
Source: check_circle
Crossref

Prolonged SARS-CoV-2 nucleic acid conversion time in military personnel outbreaks with presence of specific IgG antibodies

Journal of Medical Microbiology
2022-01-18 | Journal article
Contributors: Jhonnatan Reales Gonzalez; Diego Prada Cardozo; Sheryll Corchuelo; Gabriela Zabaleta; Zonia Alarcón; Maria T. Herrera Sepulveda; Katherine Laiton Donato; Carlos Franco Muñoz; Diego A. Alvarez Diaz; Yesith Guillermo Toloza Perez et al.
Source: check_circle
Crossref

Characterization of the emerging B.1.621 variant of interest of SARS-CoV-2

2021-05-10 | Preprint
Contributors: Katherine Laiton-Donato; Carlos Franco-Muñoz; Diego A. Álvarez-Díaz; Hector Alejandro Ruiz-Moreno; José A. Usme-Ciro; Diego Andrés Prada; Jhonnatan Reales-González; Sheryll Corchuelo; María T. Herrera-Sepúlveda; Julian Naizaque et al.
Source: check_circle
Crossref

ELIPSE-COL: A novel ELISA test based on rational envisioned synthetic peptides for detection of SARS-CoV-2 infection in Colombia

2020-11-16 | Preprint
Contributors: Adriana Arévalo; Carlos Franco-Muñoz; Sofía Duque-Beltrán; Lyda Muñoz-Galindo; María Herrera-Sepulveda; José Manuel Lozano; Luz Mary Salazar; Martha L. Ospina-Martinez; Marcela Mercado-Reyes
Source: check_circle
Crossref